Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Terminated 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Recurrence 1Polycystic Ovary Syndrome 1Infertility, Female 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Ovulation Induction × Clear all
NCT07148141 2026-01-28

FERTICAN

University Hospital, Clermont-Ferrand

Active not recruiting
100 enrolled
Breast

Breast Neoplasms, Infertility, Female

NCT02656121 2018-11-16

PCOSD

Ain Shams University

Phase 2 Completed
300 enrolled

Polycystic Ovary Syndrome

NCT00504699 2018-03-29

Safety of Ovarian Stimulation With Letrozole and Gonadotropins in Breast Cancer Patients

New York Medical College

Phase NA Terminated
120 enrolled
Breast

Breast Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡